| Year |
Citation |
Score |
| 2019 |
Lee JY, Acosta S, Tuazon JP, Xu K, Nguyen H, Lippert T, Liska MG, Semechkin A, Garitaonandia I, Gonzalez R, Kern R, Borlongan CV. Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model. Theranostics. 9: 1029-1046. PMID 30867814 DOI: 10.7150/Thno.29868 |
0.386 |
|
| 2019 |
Gonzalez R, Garitaonandia I, Semechkin A, Kern R. Derivation of Neural Stem Cells from Human Parthenogenetic Stem Cells. Methods in Molecular Biology (Clifton, N.J.). 1919: 43-57. PMID 30656620 DOI: 10.1007/978-1-4939-9007-8_4 |
0.628 |
|
| 2018 |
Garitaonandia I, Gonzalez R, Sherman G, Semechkin A, Evans A, Kern R. Novel Approach to Stem Cell Therapy in Parkinson's Disease. Stem Cells and Development. PMID 29882481 DOI: 10.1089/Scd.2018.0001 |
0.45 |
|
| 2018 |
Christiansen-Weber T, Noskov A, Cardiff D, Garitaonandia I, Dillberger A, Semechkin A, Gonzalez R, Kern R. Supplementation of Specific Carbohydrates Results in Enhanced Deposition of Chondrogenic-Specific Matrix during Mesenchymal Stem Cell Differentiation. Journal of Tissue Engineering and Regenerative Medicine. PMID 29490116 DOI: 10.1002/Term.2658 |
0.509 |
|
| 2016 |
Amir H, Touboul T, Sabatini K, Chhabra D, Garitaonandia I, Loring JF, Morey R, Laurent LC. Spontaneous Single-Copy Loss of TP53 in Human Embryonic Stem Cells Markedly Increases Cell Proliferation and Survival. Stem Cells (Dayton, Ohio). PMID 27888558 DOI: 10.1002/Stem.2550 |
0.694 |
|
| 2016 |
Garitaonandia I, Gonzalez R, Christiansen-Weber T, Abramihina T, Poustovoitov M, Noskov A, Sherman G, Semechkin A, Snyder E, Kern R. Neural Stem Cell Tumorigenicity and Biodistribution Assessment for Phase I Clinical Trial in Parkinson's Disease. Scientific Reports. 6: 34478. PMID 27686862 DOI: 10.1038/Srep34478 |
0.512 |
|
| 2016 |
Peterson SE, Garitaonandia I, Loring JF. The tumorigenic potential of pluripotent stem cells: What can we do to minimize it? Bioessays : News and Reviews in Molecular, Cellular and Developmental Biology. 38: S86-95. PMID 27417126 DOI: 10.1002/Bies.201670915 |
0.773 |
|
| 2016 |
Gonzalez R, Garitaonandia I, Poustovoitov M, Abramihina T, McEntire C, Culp B, Attwood J, Noskov A, Christiansen-Weber T, Khater M, Mora-Castilla S, To C, Crain A, Sherman G, Semechkin A, et al. Neural Stem Cells Derived from Human Parthenogenetic Stem Cells Engraft and Promote Recovery in a Nonhuman Primate Model of Parkinson's Disease. Cell Transplantation. PMID 27213850 DOI: 10.3727/096368916X691682 |
0.506 |
|
| 2015 |
Gonzalez R, Garitaonandia I, Crain A, Poustovoitov M, Abramihina T, Noskov A, Jiang C, Morey R, Laurent LC, Elsworth JD, Snyder EY, Redmond DE, Semechkin R. Proof of concept studies exploring the safety and functional activity of human parthenogenetic-derived neural stem cells for the treatment of Parkinson's disease. Cell Transplantation. 24: 681-90. PMID 25839189 DOI: 10.3727/096368915X687769 |
0.552 |
|
| 2015 |
Garitaonandia I, Amir H, Boscolo FS, Wambua GK, Schultheisz HL, Sabatini K, Morey R, Waltz S, Wang YC, Tran H, Leonardo TR, Nazor K, Slavin I, Lynch C, Li Y, et al. Increased risk of genetic and epigenetic instability in human embryonic stem cells associated with specific culture conditions. Plos One. 10: e0118307. PMID 25714340 DOI: 10.1371/Journal.Pone.0118307 |
0.56 |
|
| 2015 |
Semechkin R, Gonzalez R, Garitaonandia I, Poustovoitov M, Abramihina T, Noskov A, Snyder EY, Redmond DE. Human parthenogenetic derived neural stem cells for the treatment of parkinson’s disease Cytotherapy. 17: S16. DOI: 10.1016/J.Jcyt.2015.03.337 |
0.539 |
|
| 2013 |
Gonzalez R, Garitaonandia I, Abramihina T, Wambua GK, Ostrowska A, Brock M, Noskov A, Boscolo FS, Craw JS, Laurent LC, Snyder EY, Semechkin RA. Deriving dopaminergic neurons for clinical use. A practical approach. Scientific Reports. 3: 1463. PMID 23492920 DOI: 10.1038/Srep01463 |
0.393 |
|
| 2012 |
Nazor KL, Altun G, Lynch C, Tran H, Harness JV, Slavin I, Garitaonandia I, Müller FJ, Wang YC, Boscolo FS, Fakunle E, Dumevska B, Lee S, Park HS, Olee T, et al. Recurrent variations in DNA methylation in human pluripotent stem cells and their differentiated derivatives. Cell Stem Cell. 10: 620-34. PMID 22560082 DOI: 10.1016/J.Stem.2012.02.013 |
0.729 |
|
| 2012 |
Isaev DA, Garitaonandia I, Abramihina TV, Zogovic-Kapsalis T, West RA, Semechkin AY, Müller AM, Semechkin RA. In vitro differentiation of human parthenogenetic stem cells into neural lineages. Regenerative Medicine. 7: 37-45. PMID 22168496 DOI: 10.2217/Rme.11.110 |
0.635 |
|
| 2012 |
Semechkin R, Garitaonandia I, Abramihina T, Zogovic-Kapsalis T, West R, Mueller A, Csete M, Semechkin A. Functional Dopaminergic Neurons Derived from Human Parthenogenetic Stem Cells (IN8-1.004) Neurology. 78: IN8-1.004-IN8-1.004. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In8-1.004 |
0.5 |
|
| 2012 |
Garitaonandia I, Tran HT, Boscolo F. Culture of Human Pluripotent Stem Cells in Feeder-Free Conditions Human Stem Cell Manual. 29-40. DOI: 10.1016/B978-0-12-385473-5.00003-5 |
0.576 |
|
| 2011 |
Peterson SE, Tran HT, Garitaonandia I, Han S, Nickey KS, Leonardo T, Laurent LC, Loring JF. Teratoma generation in the testis capsule. Journal of Visualized Experiments : Jove. e3177. PMID 22158256 DOI: 10.3791/3177 |
0.738 |
|
| 2011 |
Wang YC, Nakagawa M, Garitaonandia I, Slavin I, Altun G, Lacharite RM, Nazor KL, Tran HT, Lynch CL, Leonardo TR, Liu Y, Peterson SE, Laurent LC, Yamanaka S, Loring JF. Specific lectin biomarkers for isolation of human pluripotent stem cells identified through array-based glycomic analysis. Cell Research. 21: 1551-63. PMID 21894191 DOI: 10.1038/Cr.2011.148 |
0.746 |
|
| 2011 |
Ben-Nun IF, Montague SC, Houck ML, Tran HT, Garitaonandia I, Leonardo TR, Wang YC, Charter SJ, Laurent LC, Ryder OA, Loring JF. Induced pluripotent stem cells from highly endangered species. Nature Methods. 8: 829-31. PMID 21892153 DOI: 10.1038/Nmeth.1706 |
0.713 |
|
| Show low-probability matches. |